TANIS STEVEN P,LARSEN SCOTT D,ARTMAN GERALD D III,PARKER TIMOTHY
申请号：
IN201617002533
公开号：
IN201617002533A
申请日:
2016.01.22
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The present invention relates to hydroxamate compounds and pharmaceutical compositions that are useful for treating and/or preventing metabolic inflammation mediated diseases such as diabetes obesity hypertension dyslipidemia a neurodegenerative disorder (e.g. Alzheimer s disease Parkinson s disease or Huntington s disease) or any combination thereof. Moreover the present invention also provides methods of treatment for these diseases or disorders.
